Newron Pharmaceuticals SpA operates as a biopharmaceutical company. It focuses on the development of novel therapies for patients with diseases of the central and peripheral nervous system. The firm's products include Xadago (safinamide), Evenamide (NW-3509) and Ralfinamide. The company was founded by Luca Benatti, Ruggero Fariello and Patricia Salvati in 1999 and is headquartered in Bresso, Italy.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Newron Pharmaceuticals Spa.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Newron Pharmaceuticals Spa. market cap is $186.84M.
What is the 52-week high for Newron Pharmaceuticals Spa.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Newron Pharmaceuticals Spa. 52 week high is $9.36 as of September 05, 2025.
What is the 52-week low for Newron Pharmaceuticals Spa.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Newron Pharmaceuticals Spa. 52 week low is $9.10 as of September 05, 2025.
What is Newron Pharmaceuticals Spa. stock price today?
Newron Pharmaceuticals Spa. stock price today is $9.36.
What was Newron Pharmaceuticals Spa. stock price yesterday?
Newron Pharmaceuticals Spa. stock price yesterday was $12.00.
What is the PE ratio of Newron Pharmaceuticals Spa.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Newron Pharmaceuticals Spa.’s P/E ratio is 11.40.
What is the Price-to-Book ratio of Newron Pharmaceuticals Spa.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Newron Pharmaceuticals Spa. P/B ratio is 123.7441.
What is the 50-day moving average of Newron Pharmaceuticals Spa.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Newron Pharmaceuticals Spa. 50-day moving average is $9.36.
